Merit Medical Systems Affirms FY2026 Adj EPS Guidance of $4.01-$4.15 vs $4.03 Est; Raises FY2026 Sales Guidance from $1.610B-$1.630B to $1.612B-$1.634B vs $1.619B Est

Benzinga Newsdesk www.benzinga.com Negative 61.5%

Neg 61.5% Neu 0% Pos 0%

Merit Medical Systems (NASDAQ:MMSI) affirms FY2026 Adj EPS guidance from $4.01-$4.15 to $4.01-$4.15 vs $4.03 analyst estimate. Raises FY2026 sales outlook from $1.610 billion-$1.630 billion to $1.612 billion-$1.634 billion vs $1.619 billion estimate.